D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 104 Citations 43,493 770 World Ranking 3163 National Ranking 107

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Antibiotics

Jeffrey Lipman focuses on Dosing, Intensive care medicine, Intensive care, Pharmacokinetics and Pharmacodynamics. Jeffrey Lipman interconnects Anesthesia, Antibiotics, Antibacterial agent, Clinical trial and Drug in the investigation of issues within Dosing. Jeffrey Lipman has researched Intensive care medicine in several fields, including Antimicrobial, Randomized controlled trial, Antibiotic resistance and Drug resistance.

He has included themes like Internal medicine, Epidemiology, Cohort study, Intensive care unit and Pediatrics in his Intensive care study. Jeffrey Lipman interconnects Creatinine, Renal replacement therapy, Sepsis and Renal function in the investigation of issues within Pharmacokinetics. Jeffrey Lipman works mostly in the field of Pharmacodynamics, limiting it down to topics relating to Piperacillin and, in certain cases, Minimum inhibitory concentration, as a part of the same area of interest.

His most cited work include:

  • International Study of the Prevalence and Outcomes of Infection in Intensive Care Units (1989 citations)
  • Hydroxyethyl starch or saline for fluid resuscitation in intensive care (1101 citations)
  • Pharmacokinetic issues for antibiotics in the critically ill patient. (531 citations)

What are the main themes of his work throughout his whole career to date?

Intensive care medicine, Pharmacokinetics, Dosing, Antibiotics and Intensive care are his primary areas of study. His Intensive care medicine research includes themes of Septic shock, Sepsis and Antibiotic resistance. His work carried out in the field of Pharmacokinetics brings together such families of science as Anesthesia, Renal replacement therapy and Renal function.

His work deals with themes such as Vancomycin and Therapeutic drug monitoring, Drug, which intersect with Dosing. His research integrates issues of Antimicrobial and Drug resistance in his study of Antibiotics. His biological study spans a wide range of topics, including Clinical trial, Pneumonia, Randomized controlled trial, Anesthesiology and Pediatrics.

He most often published in these fields:

  • Intensive care medicine (55.57%)
  • Pharmacokinetics (65.85%)
  • Dosing (56.53%)

What were the highlights of his more recent work (between 2017-2021)?

  • Pharmacokinetics (65.85%)
  • Dosing (56.53%)
  • Antibiotics (42.29%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Pharmacokinetics, Dosing, Antibiotics, Intensive care medicine and Internal medicine. His Pharmacokinetics study incorporates themes from Anesthesia, Renal replacement therapy and Renal function. Jeffrey Lipman does research in Dosing, focusing on Trough Concentration specifically.

His Antibiotics research integrates issues from Bacteria, Antimicrobial, In vivo and Pneumonia. When carried out as part of a general Intensive care medicine research project, his work on Intensive care unit is frequently linked to work in Narrative review, therefore connecting diverse disciplines of study. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Piperacillin/tazobactam, Piperacillin and Cefepime.

Between 2017 and 2021, his most popular works were:

  • Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit (66 citations)
  • Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance (52 citations)
  • Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance (52 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Antibiotics

The scientist’s investigation covers issues in Pharmacokinetics, Intensive care medicine, Antibiotics, Dosing and Internal medicine. Jeffrey Lipman works in the field of Pharmacokinetics, focusing on Pharmacodynamics in particular. His Intensive care medicine research also works with subjects such as

  • Intensive care most often made with reference to Septic shock,
  • Drug resistance, which have a strong connection to Minimum inhibitory concentration.

His Antibiotics research is multidisciplinary, incorporating elements of Bioanalysis, Sampling, Clinical trial and Bacteria. His research in Dosing intersects with topics in Anesthesia and Posaconazole. His Internal medicine research incorporates themes from Gastroenterology and Ceftazidime.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

International Study of the Prevalence and Outcomes of Infection in Intensive Care Units

Jean Louis Vincent;Jordi Rello;John Marshall;Eliezer Silva.
JAMA (2009)

3412 Citations

Hydroxyethyl starch or saline for fluid resuscitation in intensive care

John A. Myburgh;Simon Finfer;Rinaldo Bellomo;Laurent Billot.
The New England Journal of Medicine (2012)

1766 Citations

Assessment of the worldwide burden of critical illness: The Intensive Care Over Nations (ICON) audit

Jean Louis Vincent;John C Marshall;Silvio Antonio Ñamendys-Silva;Bruno François.
The Lancet Respiratory Medicine (2014)

773 Citations

Pharmacokinetic issues for antibiotics in the critically ill patient.

Jason A. Roberts;Jeffrey Lipman.
Critical Care Medicine (2009)

759 Citations

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

Jason A. Roberts;Sanjoy K. Paul;Murat Akova;Matteo Bassetti.
Clinical Infectious Diseases (2014)

616 Citations

Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units

Simon Finfer;Rinaldo Bellomo;Jeffrey Lipman;Craig French.
Intensive Care Medicine (2004)

593 Citations

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

Jason A Roberts;Jason A Roberts;Mohd H Abdul-Aziz;Jeffrey Lipman;Jeffrey Lipman;Johan W Mouton.
Lancet Infectious Diseases (2014)

535 Citations

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

Jason A. Roberts;Jason A. Roberts;Carl M. J. Kirkpatrick;Michael S. Roberts;Thomas A. Robertson.
Journal of Antimicrobial Chemotherapy (2009)

366 Citations

Augmented renal clearance: implications for antibacterial dosing in the critically ill

Andrew A. Udy;Andrew A. Udy;Jason A. Roberts;Jason A. Roberts;Robert J. Boots;Robert J. Boots;David L. Paterson;David L. Paterson.
Clinical Pharmacokinectics (2010)

359 Citations

Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial

Joel M. Dulhunty;Jason A. Roberts;Joshua S. Davis;Steven A. R. Webb.
Clinical Infectious Diseases (2013)

344 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jeffrey Lipman

Jason A. Roberts

Jason A. Roberts

Royal Brisbane and Women's Hospital

Publications: 171

Jean Louis Vincent

Jean Louis Vincent

Université Libre de Bruxelles

Publications: 136

Rinaldo Bellomo

Rinaldo Bellomo

University of Melbourne

Publications: 128

David P. Nicolau

David P. Nicolau

Hartford Hospital

Publications: 93

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 91

Jordi Rello

Jordi Rello

Instituto de Salud Carlos III

Publications: 89

Jean-François Timsit

Jean-François Timsit

Université Paris Cité

Publications: 88

Fabio Silvio Taccone

Fabio Silvio Taccone

Université Libre de Bruxelles

Publications: 73

Marin H. Kollef

Marin H. Kollef

Washington University in St. Louis

Publications: 58

David L. Paterson

David L. Paterson

University of Queensland

Publications: 56

Roger L. Nation

Roger L. Nation

Monash University

Publications: 53

Daniel De Backer

Daniel De Backer

Université Libre de Bruxelles

Publications: 51

Simon Finfer

Simon Finfer

George Institute for Global Health

Publications: 49

Stijn Blot

Stijn Blot

Ghent University

Publications: 47

Antoni Torres

Antoni Torres

University of Barcelona

Publications: 46

Elie Azoulay

Elie Azoulay

Université Paris Cité

Publications: 42

Something went wrong. Please try again later.